VNET Group, Inc. (NASDAQ:VNET ) Q2 2025 Earnings Conference Call August 21, 2025 8:00 AM ET Company Participants Ju Ma - Rotating President & GM of AIDC Strategic Business Group Qiyu Wang - Chief Financial Officer Xinyuan Liu - Head of Director of Investor Conference Call Participants Andy Yu - DBS Bank Ltd., Research Division Edison Lee - Jefferies LLC, Research Division Huiqun Li - BofA Securities, Research Division Timothy Zhao - Goldman Sachs Group, Inc., Research Division Xinyi Wang - UBS Investment Bank, Research Division Yue Tang - Morgan Stanley, Research Division Operator Hello, ladies and gentlemen.

Yunji Inc. (NASDAQ:YJ ) Q2 2025 Earnings Conference Call August 21, 2025 7:30 AM ET Company Participants Nan Song - Senior Financial Director Shanglue Xiao - Founder, Chairman & CEO Operator Good morning and good evening, ladies and gentlemen. Thank you for standing by, and welcome to the Yunji's First Half 2025 Earnings Conference Call.

J&J battles Stelara losses, talc lawsuits, tariffs and China headwinds while banking on growth plans and new launches to stay resilient.

StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.

ION, ION Mystery, Bounce, Court TV, Court TV Legendary Trials and Scripps News now available to Peacock subscribers CINCINNATI , Aug. 21, 2025 /PRNewswire/ -- Six national channels owned by The E.W. Scripps Company (NASDAQ: SSP) – ION, ION Mystery, Bounce, Court TV, Court TV Legendary Trials and Scripps News – are now streaming as part of Peacock's 24/7 channel offering.

MINISO Group Holding Limited (NYSE:MNSO ) Q4 2025 Earnings Conference Call August 21, 2025 5:00 AM ET Company Participants Guofu Ye - Founder, Chairman of the Board of Directors & CEO Jingjing Zhang - VP, CFO & Joint Company Secretary Conference Call Participants Junhao Fan - Huatai Securities Co., Ltd., Research Division Kin Shun Ling - Jefferies LLC, Research Division Michelle Cheng - Goldman Sachs Group, Inc., Research Division Samuel Wang - UBS Investment Bank, Research Division Guofu Ye [Audio Gap] Operating profit and adjusted EPS all exceeds expectation.

– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases –

Cracker Barrel Old Country Store Inc. (NASDAQ: CBRL) shares plunged nearly 11% on Thursday, dropping $6.47 to $52.55, after the company unveiled a new logo that has sparked heated backlash online.

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Get a deeper insight into the potential performance of PVH (PVH) for the quarter ended July 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

CBRE (CBRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of MongoDB (MDB) for the quarter ended July 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Okta (OKTA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2025.

Beyond analysts' top-and-bottom-line estimates for Ooma (OOMA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO) and certain officers. The class action, filed in the United States District Court for the Middle District of Florida, and docketed under 25-cv-01516, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CTO securities between February 18, 2021 and June 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal …

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-04110, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Flywire securities between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities …

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA) and certain officers. The class action, filed in the United States District Court for the Western District of Texas, and docketed under 25-cv-01213, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Tesla securities between April 19, 2023 and June 22, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal securities laws …

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. (“Alto” or the “Company”) (NYSE: ANRO) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about February 2, …

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) and certain officers.